Novalar Pharmaceuticals, Inc.

Quick facts

Phase 3 pipeline

• Phentolamine Mesylate (NV-101) · Cardiovascular
  Phentolamine mesylate is an alpha-adrenergic receptor antagonist that works by blocking the action of norepinephrine, a neurotransmitter that can cause blood vessels to constrict.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Novalar Pharmaceuticals, Inc. portfolio CI brief
• Novalar Pharmaceuticals, Inc. pipeline updates RSS